[[File:Prof Alimuddin Zumla 2.jpg|thumb|Professor Alimuddin Zumla]]
'''Alimuddin Zumla''' is professor of [[infectious disease]]s and [[international health]] at [[University College London Medical School]]. He specialises in infectious and tropical diseases, [[clinical immunology]], and [[internal medicine]], with a special interest in [[HIV]]/[[AIDS]], [[respiratory infection]]s, and [[diseases of poverty]].<ref>{{citation|url=http://www.postzambia.com/post-print_article.php?articleId=5826|periodical=The Post Zambia|date=2010-02-14|accessdate=2011-04-12|last=Kuwema|first=Moses|title=Zambian doctor in contention for prestigious British award}}</ref> He is internationally renowned for his extensive outputs and leadership of infectious/tropical diseases research and capacity development activities.<ref name="profile">{{citation|url=https://iris.ucl.ac.uk/iris/browse/profile?upi=AZUML60|title=Prof Ali Zumla|publisher=University College London Institutional Research Information System|accessdate=2012-12-27}}</ref>

==Early life==
Zumla was born in [[Northern Rhodesia]] (now [[Chipata]], [[Eastern Province, Zambia|Eastern Province]], [[Zambia]]).<ref name="COPM">{{citation|url=http://journals.lww.com/co-pulmonarymedicine/Fulltext/2009/05000/Editorial_introduction.1.aspx|title=Editorial introduction: Section Editor Alimuddin Zumla|journal=Current Opinion in Pulmonary Medicine|month=May|year=2009|volume=15|issue=3|page=vii|doi=10.1097/MCP.0b013e32832a1d8a}}</ref> His parents Haji Ismail and Hajiani Aman Zumla were of Gujarati [[Indians in Zambia|Indian origin]].<ref>{{citation|url=http://www.mahek.co.uk/gwg/pdfs/BharuchiVahoraPatelEnglish.pdf |editor-first=Adam|editor-last=Ghodiwala|editor2-first=Yacoob|editor2-last=Mank|page=96|title=Bharuchi Vahora Patel|publication-place=United-Kingdom|publisher=y, Gujarati Writers' Guild|year=2011|accessdate=2012-12-27}}</ref> He did his early education at the Lotus Primary School and Prince Philip Secondary School (now [[Kamwala Secondary School]]) in [[Lusaka]], and his medical training at the [[University of Zambia]]'s School of Medicine.<ref name="NSJ">{{citation|url=http://www.newsciencejournalism.net/index.php?/news_articles/view/zambian_doctor_in_prestigious_award1/|periodical=New Science Journal|date=2010-02-11|last=Kaunda|first=Danstan|title=Zambian Doctor in Prestigious Award|accessdate=2011-04-12}}</ref><ref>{{citation|periodical=Times of Zambia|last=Mwaba|first=Peter|date=2006-03-23|accessdate=2011-04-22|url=http://www.accessmylibrary.com/article-1G1-143684884/kamwala-boy-zumla-leads.html|title=Kamwala Boy Zumla Leads Fight Against Tuberculosis on World TB Day Launch}}</ref> He turned down a [[Rhodes Scholarship]] to remain in Zambia for his first degree because of his firm belief that training in Zambia would give him first-hand experience of important killer infectious diseases.<ref name="NSJ"/> In 1980, he moved to London to pursue an M.Sc. in [[tropical medicine]] at the [[University of London]].<ref name="COPM"/> In 1982, he contracted life-threatening [[tuberculous meningitis]], and was told that he would never walk again, but went on to make a remarkable recovery and return to work a year-and-a-half later to a star studded career despite disabling and painful neurological sequelae resulting from his meningitis.<ref name="NSJ"/> He went on to pursue doctoral studies on leprosy human [[monoclonal antibodies]] at the [[London School of Hygiene & Tropical Medicine]], where his 1987 dissertation (advised by [[Keith McAdam]]) merited him the Alan Woodruff Medal.<ref name="COPM"/><ref name="BTMIH">{{citation|title=The Weber Parkes Trust Medal and Prize|page=5|journal=Bulletin of Tropical Medicine and International Health|volume=7|number=3|issn=1356-0832|url=http://www.rstmh.org/sites/default/files/Vol7No31999.pdf|year=1999}}</ref><ref>{{citation|last=Zumla|first=Alimuddin|year=1987|series=Ph.D. dissertation|publisher=London School of Tropical Medicine and Hygiene|title=Characterisation of human monoclonal antibodies to phenolic glycolipid-1 from patients with leprosy and production of their anti-idiotypes}}. See library record [http://193.63.81.241/record=b1533167~S16 here].</ref>

==Career==
Following his graduation, Zumla spent a year at the London School of Hygiene and Tropical Medicine gaining the MSc degree in Clinical Tropical Diseases with a distinction and the Murgratroyd Prize. He subsequently worked at The Royal Northern and Royal Free Hospitals under the mentorship of [[David Geraint James]] obtaining his Membership of The Royal College of Physicians of London. After doing a PhD between 1985 and 1987 he worked as infectious diseases registrar and at the [[Rush Green Regional Hospital]] for Infectious Diseases in Romford under [[Dr Ming Yong]] and [[Dr Mervyn Medlock]]. Whilst working at Rush Green Hospital, he received international acclaim for rapidly identifying and notifying the first cases of the 1988 Legionnaires' Diseases outbreak which he traced back to Broadcasting House, BBC, central London(for which he received accolades from Westminster City Council and the Parliamentary Group). He subsequently spent four years in a senior registrar/honorary lecturer position at the [[Hammersmith Hospital]], [[Royal Postgraduate Medical School]] in London under [[Sir Robert Lechler]], and then two years at the [[University of Texas System|University of Texas]] Center for Infectious Diseases working with [[Herbert DuPont]].<ref name="COPM"/><ref name="BTMIH"/><ref name="BMJ">{{citation|title=BMJ Group Lifetime Achievement Award: Professor Alimuddin Zumla|journal=BMJ|year=2009|month=December|volume=339|doi=10.1136/bmj.b5574}}</ref> He then returned to his native Zambia to work on AIDS-related [[opportunistic infection]]s at the [[University Teaching Hospital]] in Lusaka before moving to [[University College London]] in 1994.<ref name="NSJ"/><ref name="BTMIH"/>

In 2003, there were media reports about a paper of Zumla's in ''[[The Lancet]]'' discussing a new test developed by a team he led for monitoring [[CD4]] immune cell counts based on dried blood samples.<ref>{{citation|url=http://news.bbc.co.uk/2/hi/health/3227257.stm|periodical=BBC News|date=2003-10-31|accessdate=2010-04-12|title=Paper test 'could help HIV care'}}</ref> Such counts are used in monitoring AIDS patients taking [[antiretroviral drug]] treatments; Zumla's subsequent work has led to development and evaluation of a range of rapid, cheap and more accessible diagnostic tests for TB and respiratory infections for use on patients in developing countries.<ref>{{citation|periodical=Nature News|last=Pearson|first=Helen|date=2003-10-31|doi=10.1038/news031027-11|title=Cheap test monitors HIV drugs: Dried blood spots could track developing world treatment success}}</ref><ref>{{citation|date=2003-11-02|accessdate=2011-04-12|url=http://www.theage.com.au/articles/2003/11/02/1067708054834.html|title=New blood test boost for HIV drive|periodical=The Age}}</ref>
Professor Alimuddin Zumla was the guest editor of the Lancet TB Series which addressed key issues around TB treatment and diagnosis.The launch was held at the World Health Organisation (WHO) in Geneva on 18 May 2010. http://www.ucl.ac.uk/news/news-articles/1005/10051901
{{As of|2011}}, Zumla is the director of the Centre for Infectious Diseases and International Health at [[UCL Medical School|University College London Medical School]], as well as a consultant in infectious diseases at [[University College Hospital]]. His current research interests include tuberculosis (particularly drug clinical trials and prevalence in London), HIV/AIDS, tropical diseases, respiratory infections (and rapid diagnostics thereof), endocarditis, biomarkers, and transrenal DNA.<ref>{{citation|url=http://www.uclh.nhs.uk/ourservices/consultants/pages/profalimuddinzumla.aspx|title=Profile: Alimuddin Zumla|publisher=[[University College Hospital]]|accessdate=2011-04-16}}</ref>

Zumla's work focuses on improving global health, especially for disadvantaged populations, with an emphasis on assisting poorer sections of the world. He established and directs a multi-country collaboration with several African, European and United States institutions on collaborative research and training program on TB and HIV/AIDS.<ref name="profile"/><ref>{{citation|url=http://www.stoptb.org/global/awards/kochon/awardees/2011.asp|title=2011 Award Winner: Professor Alimuddin Zumla|publisher=Stop TB Partnership|accessdate=2012-12-27}}</ref> During the past two decades Zumla and his collaborators have set up research and training programs in Africa, focusing attention on development of local infrastructure and capacity development.<ref>{{citation|url=http://www.unza-uclms.org/|title=Introduction|publisher=University of Zambia – University College London Medical School Research and Training Programme|accessdate=2012-12-27}}</ref> Several of his doctoral students now occupy academic positions in institutions in Africa.<ref name="COPM"/>

Zumla has established north-south partnerships for TB research. His collaborations now span five countries in Europe and 10 in sub-Saharan Africa, where he leads several multi-country research projects. His team's research findings have contributed to the development of WHO's management guidelines on treatment and prevention of TB and TB/HIV, and to improvements in the care of patients worldwide.<ref name="UCL20111102">{{citation|url=http://www.ucl.ac.uk/news/news-articles/1111/11110102-zumla-TB-prizes|title=UCL Professor wins trio of prizes for TB work|publisher=University College London|date=2011-11-02|accessdate=2012-12-27}}</ref>

==Awards==
Since his appointment at UCL in 1994, Zumla has received the Weber Parkes Trust Medal and Prize from the [[Royal College of Physicians of London]] in 1999;<ref name="BTMIH"/> the Albert Chalmers Medal from the [[Royal Society of Tropical Medicine and Hygiene]]in 2002; the Windrush Award for Academic Achievement in 2003; and the 2005 Professional of the year by the "Muslim News" ''The Muslim News2005 Awards for Excellence''.<ref>{{citation|url=http://www.muslimnews.co.uk/paper/index.php?article=1880|periodical=Muslim News|date=2005-02-25|accessdate=2011-04-12|title=Muslim News Awards for Excellence 2005 Shortlist}}</ref> In 2011 and 2012, Zumla received four more major international prizes for his work combating tuberculosis, TB/HIV/AIDS, and other respiratory infectious diseases. These recent spate of awards in include: the UK India International Foundation Science Award (2011); the University of Amsterdam Spinoza Leerstoel award (2011); and the World Health Organisation (WHO) STOP TB Partnership Kochon Prize and Medal (2011) and the Karolinska Institutet, Sweden 2012 Annual Science Prize (2012).<ref name="UCL20111102"/> 

In October 2012, Zumla was awarded the highest Zambian civilian award by Zambian president [[Michael Sata]] of Zambia for his outstanding contributions to infectious diseases research in sub-Saharan Africa, development of Zambia's health sector, and training of numerous health personnel. The award, The Grand Commander of the Order of Distinguished Services First Division, was bestowed on Zumla on the 48th anniversary of Zambia's Independence.<ref>{{citation|url=http://www.times.co.zm/?p=16953|title=Sata honours wives of freedom fighters|work=Times of Zambia|date=2012-10-24|accessdate=2012-12-27}}</ref><ref>http://www.daily-mail.co.zm/?p=17832</ref>{{dead link|date=December 2012}}

He has several honorary and visiting professorships from European and African universities, and memberships of numerous international committees and advisory expert groups. He is guest editor and editorial board member of several major medical journals.<ref>http://www.times.co.zm/?p=17289</ref>{{dead link|date=December 2012}}

Zumla is Chairman of the International Scientific Advisory Expert Group to the United Kingdom All Party Parliamentary Group on Global Tuberculosis and member of Court of Governors of the London School of Hygiene and Tropical Medicine.<ref name="UCL20111102"/>

==Quotes==
*"  One does not need a Rolls Royce to make a journey — it is the careful and committed driver who is important"<ref name="NSJ"/>

==Selected works==
Zumla has authored 406 publications and edited/published 19 medical textbooks, three of which are globally acknowledged classics: ''Manson's Tropical Diseases'' 21st and 22nd editions, ''Tuberculosis: A Comprehensive Clinical Reference'' which involves 156 global TB experts writing 104 chapters on all aspects of paediatric and adult TB, and ''Granulomatous Disorders'' co-edited with D. G. James.<ref>{{cite web|url= http://www.ucl.ac.uk/infection-immunity/research/res_ccm/ccm_zum-auto |title= The  University College London Intranet, which it would appear can only be accessed by UCL students}}</ref>

===Books===
*{{citation|title=AIDS and respiratory medicine|first=Alimuddin|last=Zumla|first2=Margaret A.|last2=Johnson|first3=Robert|last3=Miller|year=1997|publisher=Chapman & Hall Medical|isbn=978-0-412-60140-8}}
*{{citation|title=Tuberculosis: An Issue of Clinics in Chest Medicine|first=Alimuddin|last=Zumla|first2=H. Simon|last2=Schaaf|year=2009|publisher=Elsevier - Health Sciences Division|isbn=978-1-4377-1804-1}}
* "Travel Medicine,An issue of infectious diseases clinics"  http://www.us.elsevierhealth.com/Medicine/Infectious-Disease/book/9781455748983/Travel-Medicine-An-Issue-of-Infectious-Disease-Clinics/
* "Tuberculosis: A Comprehensive Clinical Reference"  H. Simon Schaaf (Author), Alimuddin Zumla (Author) 

===Edited works===
*{{citation|editor-last=Cook|editor-first=Gordon C|editor2-last=Zumla|editor2-first=Alimuddin|title=Manson's Tropical Diseases|edition=22nd|publisher=Elsevier Harcourt Brace Publishing Group|publication-place=London|year=2008|isbn=978-1-4160-4470-3}}
*{{citation|editor-first=H. Simon|editor-last=Schaaf|editor2-first=Alimuddin|editor2-last=Zumla|title=Tuberculosis: a comprehensive clinical reference|isbn=978-1-4160-3988-4|year=2009|publisher=Saunders/Elsevier}}

===Journal papers===
*{{citation|pmid=12383985|year=2002|last1=Mwinga|first1=A.|last2=Nunn|first2=A.|last3=Ngwira|first3=B.|last4=Chintu|first4=C.|last5=Warndorff|first5=D.|last6=Fine|first6=P.|last7=Darbyshire|first7=J.|last8=Zumla|first8=A.|title=Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial|volume=360|issue=9339|pages=1050&ndash;5|doi=10.1016/S0140-6736(02)11141-X|journal=The Lancet}}
*{{citation|pmid=12383668|year=2002|last1=Chintu|first1=C.|last2=Mudenda|first2=V.|last3=Lucas|first3=S.|last4=Nunn|first4=A.|last5=Lishimpi|first5=K.|last6=Maswahu|first6=D.|last7=Kasolo|first7=F.|last8=Mwaba|first8=P.|last9=Bhat|first9=G.|last10=Terunuma|first10=H.|last11=Zumla|first11=A.|title=Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study|volume=360|issue=9338|pages=985&ndash;90|doi=10.1016/S0140-6736(02)11082-8|journal=The Lancet}}
*{{citation|pmid=14697808|year=2003|last1=Mwaba|first1=P.|last2=Cassol|first2=S.|last3=Nunn|first3=A.|last4=Pilon|first4=R.|last5=Chintu|first5=C.|last6=Janes|first6=M.|last7=Zumla|first7=A.|title=Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients|volume=362|issue=9401|pages=2067&ndash;8|doi=10.1016/S0140-6736(03)15103-3|journal=The Lancet}}
*{{citation|pmid=14602443|year=2003|last1=Mwaba|first1=P.|last2=Cassol|first2=S.|last3=Pilon|first3=R.|last4=Chintu|first4=C.|last5=Janes|first5=M.|last6=Nunn|first6=A.|last7=Zumla|first7=A.|title=Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients|volume=362|issue=9394|pages=1459&ndash;60|doi=10.1016/S0140-6736(03)14693-4|journal=The Lancet}}
*{{citation|pmid=15555666|year=2004|last1=Chintu|first1=C.|last2=Bhat|first2=GJ.|last3=Walker|first3=AS.|last4=Mulenga|first4=V.|last5=Sinyinza|first5=F.|last6=Lishimpi|first6=K.|last7=Farrelly|first7=L.|last8=Kaganson|first8=N.|last9=Zumla|first9=A.|title=Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial|volume=364|issue=9448|pages=1865&ndash;71|doi=10.1016/S0140-6736(04)17442-4|journal=The Lancet}}
*{{citation|pmid=16546520|year=2006|last1=Zumla|first1=A|last2=Mullan|first2=Z|title=Turning the tide against tuberculosis|volume=367|issue=9514|pages=877&ndash;8|doi=10.1016/S0140-6736(06)68355-4|journal=The Lancet}}
*{{citation|pmid=16546544|year=2006|last1=Perkins|first1=M. D.|last2=Roscigno|first2=G.|last3=Zumla|first3=A.|title=Progress towards improved tuberculosis diagnostics for developing countries|volume=367|issue=9514|pages=942&ndash;3|doi=10.1016/S0140-6736(06)68386-4|journal=The Lancet}}
*{{citation|pmid=17482983|year=2007|last1=Griffiths|first1=C.|last2=Sturdy|first2=P.|last3=Brewin|first3=P.|last4=Bothamley|first4=G.|last5=Eldridge|first5=S.|last6=Martineau|first6=A.|last7=MacDonald|first7=M.|last8=Ramsay|first8=J.|last9=Tibrewal|first9=S.|title=Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial|volume=369|issue=9572|pages=1528&ndash;34|doi=10.1016/S0140-6736(07)60707-7|journal=The Lancet}}
*{{citation|title=Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ)|first=Andrew J.|last=Nunn|first2=Peter B.|last2=Mwaba|first3=Chifumbe|last3=Chintu|first4=Angela M.|last4=Crook|first5=Janet H.|last5=Darbyshire|first6=Yusuf|last6=Ahmed|first7=Alimuddin I.|last7=Zumla|doi=10.1111/j.1365-3156.2011.02731.x|journal=Tropical Medicine & International Health|volume=16|number=4|pages=518–526|month=April|year=2011}}

==References==
{{reflist|2}}

==External links==
*{{official| https://iris.ucl.ac.uk/iris/browse/profile?upi=AZUML60}}
*http://allafrica.com/stories/201210270347.html

{{DEFAULTSORT:Zumla, Alimuddin}}
[[Category:Pathologists]]
[[Category:Zambian Muslims]]
[[Category:Zambian physicians]]
[[Category:Zambian people of Indian descent]]
[[Category:Zambian emigrants to the United Kingdom]]
[[Category:Year of birth missing (living people)]]